✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAgingSafety Dr. Caplan’s Take “What we’re seeing with cannabinoids and hepatic steatosis is a genuine...
Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDHempSafety Why This Matters This research suggesting CBD and CBG may reduce hepatic steatosis and...
Daily Digest: Last 7 Hours: Cannabis, Liver Disease, and the Policy Gaps That Still Haunt Patients — March 07, 2026
A synthesis of 12 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDAnxietyResearchMental Health Why This Matters Clinicians treating older adults with anxiety disorders may now consider...
Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAgingSafety Why This Matters This study provides reassurance for older adults considering cannabis for symptom...
Daily Digest: Last 4 Hours: Cannabinoids and Fatty Liver Disease Show Promise While Regulatory Gaps Widen Across States — March 06, 2026
A synthesis of 6 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Cannabis Compounds Exhibit Potential in Combatting Fatty Liver Disease
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAging Why This Matters Clinicians managing patients with fatty liver disease now have preliminary evidence...
Daily Digest: Last 6 Hours: Cognitive Safety, Liver Disease Breakthroughs, and the Drug Testing Problem That Won’t Go Away — March 06, 2026
A synthesis of 20 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Daily Digest: Last 48 Hours: Cognitive Safety, End-of-Life Access, and the Impairment Testing Problem — March 06, 2026
A synthesis of 102 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Natural Approaches to Managing Chronic Inflammation – WorldHealth.net
WHY IT MATTERS: Patients managing chronic inflammatory conditions now have growing scientific rationale to discuss cannabinoid-based options with their physicians, but translating that science into safe, effective protocols still requires careful medical guidance rather than self-directed supplementation. CLINICAL OVERVIEW: The endocannabinoid system is a legitimate and increasingly well-characterized biological network that helps regulate immune tone and inflammatory signaling through receptors distributed throughout immune tissues, the gut, and the central nervous system. Phytocannabinoids such as CBD and THC interact with this system in ways that can modulate cytokine production, microglial activation, and oxidative stress pathways relevant to chronic inflammatory conditions.